Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares US Medical Devices UCITS ETF EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-11-11 (Tuesday)	81,742	USD 6,961,149	USD 6,961,149	0	USD 88,282	USD 85.16	USD 84.08
2025-11-10 (Monday)	81,742	USD 6,872,867	USD 6,872,867	0	USD 56,402	USD 84.08	USD 83.39
2025-11-07 (Friday)	81,742	USD 6,816,465	USD 6,816,465	0	USD 77,655	USD 83.39	USD 82.44
2025-11-06 (Thursday)	81,742	USD 6,738,810	USD 6,738,810	-1,268	USD -137,738	USD 82.44	USD 82.84
2025-11-05 (Wednesday)	83,010	USD 6,876,548	USD 6,876,548	0	USD -108,744	USD 82.84	USD 84.15
2025-11-04 (Tuesday)	83,010	USD 6,985,292	USD 6,985,292	634	USD 142,318	USD 84.15	USD 83.07
2025-11-03 (Monday)	82,376	USD 6,842,974	USD 6,842,974	0	USD 51,073	USD 83.07	USD 82.45
2025-10-31 (Friday)	82,376	USD 6,791,901	USD 6,791,901	0	USD -84,847	USD 82.45	USD 83.48
2025-10-30 (Thursday)	82,376	USD 6,876,748	USD 6,876,748	-1,902	USD -92,200	USD 83.48	USD 82.69
2025-10-29 (Wednesday)	84,278	USD 6,968,948	USD 6,968,948	0	USD 42,139	USD 82.69	USD 82.19
2025-10-28 (Tuesday)	84,278	USD 6,926,809	USD 6,926,809	0	USD 115,461	USD 82.19	USD 80.82
2025-10-27 (Monday)	84,278	USD 6,811,348	USD 6,811,348	0	USD 397,792	USD 80.82	USD 76.1

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00BMX0DF60

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -1,268 82.965 81.690 81.818 USD -103,745 74.04 Loss of -9,861 on sale
2025-11-04 BUY 634 84.830 82.890 83.084 USD 52,675 73.95
2025-10-30 SELL -1,902 83.710 82.350 82.486 USD -156,888 73.81 Loss of -16,503 on sale
2025-10-23 SELL -634 76.530 76.860 76.827 USD -48,708 73.66 Loss of -2,010 on sale
2025-10-22 BUY 1,268 76.840 78.330 78.181 USD 99,134 73.64
2025-10-20 BUY 634 75.290 75.570 75.542 USD 47,894 73.62
2025-10-16 BUY 634 72.650 73.790 73.676 USD 46,711 73.62
2025-09-25 BUY 5,072 75.270 75.530 75.504 USD 382,956 73.47
2025-08-22 SELL -2,536 81.830 81.840 81.839 USD -207,544 73.11 Loss of -22,149 on sale
2025-06-27 SELL -1,264 78.210 78.250 78.246 USD -98,903 72.37 Loss of -7,424 on sale
2025-06-12 BUY 1,911 75.890 76.620 76.547 USD 146,281 72.18
2025-06-10 SELL -10,192 75.800 76.550 76.475 USD -779,433 72.12 Loss of -44,342 on sale
2025-06-09 SELL -12,103 76.360 77.370 77.269 USD -935,187 72.09 Loss of -62,663 on sale
2025-05-30 SELL -1,274 78.220 78.300 78.292 USD -99,744 71.81 Loss of -8,258 on sale
2025-05-19 BUY 637 78.040 78.260 78.238 USD 49,838 71.45
2025-05-16 BUY 229 78.000 78.280 78.252 USD 17,920 71.39
2025-05-09 SELL -3,180 73.680 74.910 74.787 USD -237,823 71.20 Loss of -11,405 on sale
2025-04-23 SELL -637 70.460 72.750 72.521 USD -46,196 70.73 Loss of -1,140 on sale
2025-04-17 SELL -636 71.530 72.150 72.088 USD -45,848 70.73 Loss of -862 on sale
2025-04-10 BUY 5,088 68.260 69.350 69.241 USD 352,298 70.78
2025-04-04 SELL -1,272 69.360 71.720 71.484 USD -90,928 70.87 Loss of -776 on sale
2025-04-02 SELL -1,272 72.050 72.360 72.329 USD -92,002 70.86 Loss of -1,869 on sale
2025-03-31 SELL -1,908 72.480 72.740 72.714 USD -138,738 70.83 Loss of -3,601 on sale
2025-03-19 SELL -636 70.900 71.200 71.170 USD -45,264 70.81 Loss of -232 on sale
2025-02-28 SELL -1,272 71.620 71.770 71.755 USD -91,272 70.95 Loss of -1,028 on sale
2025-02-21 BUY 284 73.300 74.660 74.524 USD 21,165 70.84
2025-02-18 BUY 251 75.670 76.670 76.570 USD 19,219 70.59
2025-02-05 BUY 1,899 72.100 72.360 72.334 USD 137,362 70.03
2025-02-04 BUY 2,532 71.330 71.430 71.420 USD 180,835 70.00
2025-01-29 SELL -633 71.130 72.990 72.804 USD -46,085 69.78 Loss of -1,913 on sale
2025-01-23 SELL -633 68.930 69.400 69.353 USD -43,900 69.77 Profit of 262 on sale
2025-01-02 SELL -3,557 72.590 74.500 74.309 USD -264,317 69.68 Loss of -16,462 on sale
2024-12-04 BUY 1,938 74.200 74.680 74.632 USD 144,637 69.18
2024-12-03 SELL -646 70.200 70.570 70.533 USD -45,564 69.14 Loss of -899 on sale
2024-12-02 SELL -7,740 70.530 70.530 70.530 USD -545,902 69.09 Loss of -11,160 on sale
2024-11-29 SELL -12,920 71.350 71.710 71.674 USD -926,028 69.00 Loss of -34,579 on sale
2024-11-27 SELL -1,938 72.070 72.630 72.574 USD -140,648 68.73 Loss of -7,449 on sale
2024-11-19 BUY 656 70.200 70.260 70.254 USD 46,087 68.08
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-1,268	82.965	81.690	81.818	USD -103,745	74.04 Loss of -9,861 on sale
2025-11-04	BUY	634	84.830	82.890	83.084	USD 52,675	73.95
2025-10-30	SELL	-1,902	83.710	82.350	82.486	USD -156,888	73.81 Loss of -16,503 on sale
2025-10-23	SELL	-634	76.530	76.860	76.827	USD -48,708	73.66 Loss of -2,010 on sale
2025-10-22	BUY	1,268	76.840	78.330	78.181	USD 99,134	73.64
2025-10-20	BUY	634	75.290	75.570	75.542	USD 47,894	73.62
2025-10-16	BUY	634	72.650	73.790	73.676	USD 46,711	73.62
2025-09-25	BUY	5,072	75.270	75.530	75.504	USD 382,956	73.47
2025-08-22	SELL	-2,536	81.830	81.840	81.839	USD -207,544	73.11 Loss of -22,149 on sale
2025-06-27	SELL	-1,264	78.210	78.250	78.246	USD -98,903	72.37 Loss of -7,424 on sale
2025-06-12	BUY	1,911	75.890	76.620	76.547	USD 146,281	72.18
2025-06-10	SELL	-10,192	75.800	76.550	76.475	USD -779,433	72.12 Loss of -44,342 on sale
2025-06-09	SELL	-12,103	76.360	77.370	77.269	USD -935,187	72.09 Loss of -62,663 on sale
2025-05-30	SELL	-1,274	78.220	78.300	78.292	USD -99,744	71.81 Loss of -8,258 on sale
2025-05-19	BUY	637	78.040	78.260	78.238	USD 49,838	71.45
2025-05-16	BUY	229	78.000	78.280	78.252	USD 17,920	71.39
2025-05-09	SELL	-3,180	73.680	74.910	74.787	USD -237,823	71.20 Loss of -11,405 on sale
2025-04-23	SELL	-637	70.460	72.750	72.521	USD -46,196	70.73 Loss of -1,140 on sale
2025-04-17	SELL	-636	71.530	72.150	72.088	USD -45,848	70.73 Loss of -862 on sale
2025-04-10	BUY	5,088	68.260	69.350	69.241	USD 352,298	70.78
2025-04-04	SELL	-1,272	69.360	71.720	71.484	USD -90,928	70.87 Loss of -776 on sale
2025-04-02	SELL	-1,272	72.050	72.360	72.329	USD -92,002	70.86 Loss of -1,869 on sale
2025-03-31	SELL	-1,908	72.480	72.740	72.714	USD -138,738	70.83 Loss of -3,601 on sale
2025-03-19	SELL	-636	70.900	71.200	71.170	USD -45,264	70.81 Loss of -232 on sale
2025-02-28	SELL	-1,272	71.620	71.770	71.755	USD -91,272	70.95 Loss of -1,028 on sale
2025-02-21	BUY	284	73.300	74.660	74.524	USD 21,165	70.84
2025-02-18	BUY	251	75.670	76.670	76.570	USD 19,219	70.59
2025-02-05	BUY	1,899	72.100	72.360	72.334	USD 137,362	70.03
2025-02-04	BUY	2,532	71.330	71.430	71.420	USD 180,835	70.00
2025-01-29	SELL	-633	71.130	72.990	72.804	USD -46,085	69.78 Loss of -1,913 on sale
2025-01-23	SELL	-633	68.930	69.400	69.353	USD -43,900	69.77 Profit of 262 on sale
2025-01-02	SELL	-3,557	72.590	74.500	74.309	USD -264,317	69.68 Loss of -16,462 on sale
2024-12-04	BUY	1,938	74.200	74.680	74.632	USD 144,637	69.18
2024-12-03	SELL	-646	70.200	70.570	70.533	USD -45,564	69.14 Loss of -899 on sale
2024-12-02	SELL	-7,740	70.530	70.530	70.530	USD -545,902	69.09 Loss of -11,160 on sale
2024-11-29	SELL	-12,920	71.350	71.710	71.674	USD -926,028	69.00 Loss of -34,579 on sale
2024-11-27	SELL	-1,938	72.070	72.630	72.574	USD -140,648	68.73 Loss of -7,449 on sale
2024-11-19	BUY	656	70.200	70.260	70.254	USD 46,087	68.08

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam